Andreas A Argyriou, Spyridon Papapetropoulos. Show Affiliations »
Abstract
Mesh: See more » Botulinum Toxins, Type A/therapeutic useExtremities/physiopathologyHumansMovement Disorders/complicationsMovement Disorders/drug therapyNeuromuscular Agents/therapeutic usePain/complicationsPain/drug therapy
Substances: See more » Neuromuscular AgentsBotulinum Toxins, Type A
Year: 2010 PMID: 19425081 DOI: 10.1002/mds.22602
Source DB: PubMed Journal: Mov Disord ISSN: 0885-3185 Impact factor: 10.338